Your browser doesn't support javascript.
loading
Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulation.
Wu, Lan; Seung, Edward; Xu, Ling; Rao, Ercole; Lord, Dana M; Wei, Ronnie R; Cortez-Retamozo, Virna; Ospina, Beatriz; Posternak, Valeriya; Ulinski, Gregory; Piepenhagen, Peter; Francesconi, Elisa; El-Murr, Nizar; Beil, Christian; Kirby, Patrick; Li, Aiqun; Fretland, Jennifer; Vicente, Rita; Deng, Gejing; Dabdoubi, Tarik; Cameron, Beatrice; Bertrand, Thomas; Ferrari, Paul; Pouzieux, Stéphanie; Lemoine, Cendrine; Prades, Catherine; Park, Anna; Qiu, Huawei; Song, Zhili; Zhang, Bailin; Sun, Fangxian; Chiron, Marielle; Rao, Srinivas; Radosevic, Katarina; Yang, Zhi-Yong; Nabel, Gary J.
Afiliación
  • Wu L; Sanofi Research and Development, Sanofi North America, Cambridge, MA, USA.
  • Seung E; Sanofi Research and Development, Sanofi North America, Cambridge, MA, USA.
  • Xu L; Sanofi Research and Development, Sanofi North America, Cambridge, MA, USA.
  • Rao E; Sanofi Research and Development, Sanofi Frankfurt, Frankfurt, Germany.
  • Lord DM; Sanofi Research and Development, Sanofi North America, Cambridge, MA, USA.
  • Wei RR; Sanofi Research and Development, Sanofi North America, Cambridge, MA, USA.
  • Cortez-Retamozo V; Sanofi Research and Development, Sanofi North America, Cambridge, MA, USA.
  • Ospina B; Sanofi Research and Development, Sanofi North America, Cambridge, MA, USA.
  • Posternak V; Sanofi Research and Development, Sanofi North America, Cambridge, MA, USA.
  • Ulinski G; Sanofi Research and Development, Sanofi North America, Cambridge, MA, USA.
  • Piepenhagen P; Sanofi Research and Development, Sanofi North America, Cambridge, MA, USA.
  • Francesconi E; Sanofi Research and Development, Sanofi Vitry, Paris, France.
  • El-Murr N; Sanofi Research and Development, Sanofi Vitry, Paris, France.
  • Beil C; Sanofi Research and Development, Sanofi Frankfurt, Frankfurt, Germany.
  • Kirby P; Sanofi Research and Development, Sanofi North America, Cambridge, MA, USA.
  • Li A; Sanofi Research and Development, Sanofi North America, Cambridge, MA, USA.
  • Fretland J; Sanofi Research and Development, Sanofi North America, Cambridge, MA, USA.
  • Vicente R; Sanofi Research and Development, Sanofi Vitry, Paris, France.
  • Deng G; Sanofi Research and Development, Sanofi North America, Cambridge, MA, USA.
  • Dabdoubi T; Sanofi Research and Development, Sanofi Vitry, Paris, France.
  • Cameron B; Sanofi Research and Development, Sanofi Vitry, Paris, France.
  • Bertrand T; Sanofi Research and Development, Sanofi Vitry, Paris, France.
  • Ferrari P; Sanofi Research and Development, Sanofi Vitry, Paris, France.
  • Pouzieux S; Sanofi Research and Development, Sanofi Vitry, Paris, France.
  • Lemoine C; Sanofi Research and Development, Sanofi Vitry, Paris, France.
  • Prades C; Sanofi Research and Development, Sanofi Vitry, Paris, France.
  • Park A; Sanofi Research and Development, Sanofi North America, Cambridge, MA, USA.
  • Qiu H; Sanofi Research and Development, Sanofi North America, Cambridge, MA, USA.
  • Song Z; Sanofi Research and Development, Sanofi North America, Cambridge, MA, USA.
  • Zhang B; Sanofi Research and Development, Sanofi North America, Cambridge, MA, USA.
  • Sun F; Sanofi Research and Development, Sanofi North America, Cambridge, MA, USA.
  • Chiron M; Sanofi Research and Development, Sanofi Vitry, Paris, France.
  • Rao S; Sanofi Research and Development, Sanofi North America, Cambridge, MA, USA.
  • Radosevic K; Sanofi Research and Development, Sanofi Vitry, Paris, France.
  • Yang ZY; Sanofi Research and Development, Sanofi North America, Cambridge, MA, USA. zhi-yong.yang@sanofi.com.
  • Nabel GJ; Sanofi Research and Development, Sanofi North America, Cambridge, MA, USA. Gary.Nabel@sanofi.com.
Nat Cancer ; 1(1): 86-98, 2020 01.
Article en En | MEDLINE | ID: mdl-35121834
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Anticuerpos Biespecíficos / Mieloma Múltiple Límite: Animals Idioma: En Revista: Nat Cancer Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Anticuerpos Biespecíficos / Mieloma Múltiple Límite: Animals Idioma: En Revista: Nat Cancer Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos